Anticancer activity of palladium-based complexes against triple-negative breast cancer
•TNBC is an unmet medical need with poor survival rates and no targeted therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 Pd(II) complexes studied in TNBC cell lines is presented.•Pd(II) complexes show promising cancer selectivity and activity against TNBC. Tre...
Saved in:
Published in | Drug discovery today Vol. 24; no. 4; pp. 1044 - 1058 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!